We are live on
!
Find out more
PA
Profund Advisors Portfolio holdings
AUM
$2.72B
1-Year Est. Return
47.27%
This Fund
S&P 500
This Quarter
Est. Return
-1.75%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$1.81B
AUM Growth
-$55.5M
(-3%)
Cap. Flow
+$3.56M
Cap. Flow
% of AUM
0.2%
Top 10 Holdings %
Top 10 Hldgs %
31.67%
Holding
1,104
New
38
Increased
236
Reduced
694
Closed
136
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$6.77M |
| 2 |
PepsiCo
PEP
|
+$4.31M |
| 3 |
Costco
COST
|
+$4.26M |
| 4 |
Adobe
ADBE
|
+$3.9M |
| 5 |
Advanced Micro Devices
AMD
|
+$3.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$14.7M |
| 2 |
NVIDIA
NVDA
|
+$14.6M |
| 3 |
Amazon
AMZN
|
+$11.2M |
| 4 |
Tesla
TSLA
|
+$6.79M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$4.61M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.18% |
| 2 | Healthcare | 14.97% |
| 3 | Consumer Discretionary | 11.55% |
| 4 | Communication Services | 9.62% |
| 5 | Energy | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Corcept Therapeutics
CORT
$10.2B
| $312K | 0.02% |
11,457
-2,792
| -20% | -$80.8K |
|
652
Regions Financial
RF
$26.3B
| $311K | 0.02% |
18,093
-1,262
| -7% | -$23.9K |
|
653
Aecom
ACM
$9.07B
| $311K | 0.02% |
3,747
-536
| -13% | -$46.2K |
|
654
Vistra
VST
$55.1B
| $309K | 0.02% |
+9,326
| New | +$280K |
|
655
Simpson Manufacturing
SSD
$7.98B
| $308K | 0.02% |
2,059
-136
| -6% | -$20.7K |
|
656
Cabaletta Bio
CABA
$439M
| $306K | 0.02% |
+20,121
| New | +$275K |
|
|
DCPH
657
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $306K | 0.02% |
24,055
-18,030
| -43% | -$249K |
|
658
Tenaris
TS
$29.1B
| $304K | 0.02% |
9,617
-568
| -6% | -$18.4K |
|
|
CIVI
659
DELISTED
Civitas Resources
CIVI
| $303K | 0.02% |
3,752
+450
| +14% | +$34.8K |
|
660
VeriSign
VRSN
$25.3B
| $303K | 0.02% |
1,497
-216
| -13% | -$44.9K |
|
661
Las Vegas Sands
LVS
$30.5B
| $302K | 0.02% |
6,590
-1,678
| -20% | -$90.7K |
|
662
Aldeyra Therapeutics
ALDX
$91.7M
| $301K | 0.02% |
45,104
-773
| -2% | -$5.74K |
|
663
Anavex Life Sciences
AVXL
$222M
| $301K | 0.02% |
45,965
-17,689
| -28% | -$141K |
|
664
UFP Industries
UFPI
$4.97B
| $300K | 0.02% |
2,934
-212
| -7% | -$21.4K |
|
665
Selective Insurance
SIGI
$5.74B
| $300K | 0.02% |
2,903
-196
| -6% | -$19.7K |
|
666
Dynatrace
DT
$12.1B
| $299K | 0.02% |
6,398
-403
| -6% | -$19.8K |
|
667
ATI
ATI
$27B
| $299K | 0.02% |
7,260
-520
| -7% | -$23.1K |
|
668
Huntington Bancshares
HBAN
$35.1B
| $299K | 0.02% |
28,710
-2,316
| -7% | -$26K |
|
669
Fortive
FTV
$19B
| $299K | 0.02% |
5,343
-116
| -2% | -$6.67K |
|
670
HealthEquity
HQY
$7.91B
| $298K | 0.02% |
4,078
-279
| -6% | -$18.8K |
|
671
Equity Residential
EQR
$25.4B
| $298K | 0.02% |
5,070
-86
| -2% | -$5.56K |
|
|
SLRN
672
DELISTED
ACELYRIN
SLRN
| $297K | 0.02% |
+29,232
| New | +$621K |
|
673
Molina Healthcare
MOH
$10.3B
| $297K | 0.02% |
905
-24
| -3% | -$7.55K |
|
674
Ingersoll Rand
IR
$33B
| $295K | 0.02% |
4,623
-82
| -2% | -$5.46K |
|
675
Valley National Bancorp
VLY
$7.93B
| $294K | 0.02% |
34,386
-5,496
| -14% | -$49.9K |
|
Similar funds
MASUI
XL
MSL
CA
TAM
NCM
GC
FNF
Profund Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Profund Advisors held 1,104 positions worth $1.81B, down 3% from $1.86B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Profund Advisors's Q3 2023 filing shows 38 new, 236 increased, 694 reduced and 136 closed positions. Its largest new stake was Trade Desk: 28,226 shares worth $2.21M. The largest sale was Microsoft, an estimated $14.7M.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Profund Advisors's largest Q3 2023 buy was Trade Desk: 28,226 shares worth $2.21M.
- Profund Advisors added most to Broadcom in Q3 2023, an estimated $6.77M increase.
- Profund Advisors's biggest Q3 2023 reduction was Microsoft, cutting an estimated $14.7M.
- Profund Advisors fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $1.63M.
- Profund Advisors's ten largest holdings make up 32% of its $1.81B portfolio in Q3 2023.
- Profund Advisors opened 38 new positions and closed 136 in Q3 2023.
- Profund Advisors's portfolio value fell 3% quarter-over-quarter to $1.81B.
Based on Profund Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.